Medicine
Clinolipid 16 g/4 g per 100 mL injectable emulsion
Clinolipid 16 g/4 g per 100 mL injectable emulsion is a prescription medicine containing Olive oil and Soybean oil for intravenous use, marketed by Baxter Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in overpouch until ready to use.
Key facts
- Active ingredient (INN)
- Olive oil and Soybean oil
- Brand
- Clinolipid
- Strength
- 16 g/4 g per 100 mL
- Dosage form
- Injectable emulsion
- Route
- Intravenous
- Packs
- 15 bags of 100 mL
- Marketing authorisation holder
- Baxter Healthcare
- Manufacturer
- Baxter Healthcare
- Origin register
- US FDA, United States
- Storage
- Store in overpouch until ready to use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 January 2016
- Identifiers
- RxCUI 1986373, 1986378, 1986381 +5DailyMed set ID ae98eb03-c0e7-49d1-b024-77968e3d9d6eNDC 0338-9540Application NDA204508
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 15 bag in 1 carton / 100 mL in 1 bag | 0338-9540-05 | Baxter Healthcare | 1 January 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 October 2013 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Olive oil and Soybean oil
Clinical summary
Olive oil and Soybean oil is a fixed-dose combination medicine indicated in adults and pediatric patients, including term and preterm neonates, among other approved uses. MedsAcross supplies Olive oil and Soybean oil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Olive oil and Soybean oilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Clinolipid prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Clinolipid 16 g/4 g per 100 mL injectable emulsion for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.